Simpson Thacher & Bartlett acted for Centro de Imagem Diagnósticos S.A. – Alliar on its initial public offering of 33,709,880 shares of its common shares and listing on the São Paulo Stock Exchange (BM&FBovespa).
The common shares were offered to the public in Brazil, to certain qualified institutional buyers under Rule 144A in the United States, and to non-U.S. persons outside the United States in reliance upon Regulation S. The offering raised more than R$674.2 million (approximately US$210.6 million) in gross proceeds, pending exercise of the overallotment option.
Alliar is a provider of medical diagnostic services in Brazil, including diagnostic imaging, nuclear medicine and laboratory testing services. The offering, which closed on November 1, 2016, marks the first IPO by a Brazilian company since June 2015.
Partners Grenfel S. Calheiros and Todd Crider led the Simpson Thacher lawyers in NY and Sao Paulo which teamed up to advise Alliar.
Alliar retained Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga as counsel on matters that pertain to Brazilian law.
The Brazilian underwriters and placement agents instructed Cleary Gottlieb as US federal law and New York state law counsel and Lefosse Advogados for Brazilian law.